The Safety and Efficacy of Rituximab-Based Regimen in Atypical Membranous Nephropathy: A Single Center Retrospective Cohort Study.

Yanan LiuShuo ZhangRongrong HuChao LiGang ChenXiaoxiao ShiYan LiuKe ZhengHang LiYubing WenXuemei LiXuewang LiPeng XiaYan Qin

Published in: International journal of general medicine (2023)

In our study, AMN patients obtained proteinuria remission in a lower percentage compared with IMN patients. In general, rituximab-based therapy is effective in AMN patients with an acceptable safety profile.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
prognostic factors
peritoneal dialysis
rheumatoid arthritis
stem cells
diffuse large b cell lymphoma
patient reported outcomes
bone marrow
smoking cessation